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Background:  Endocardial and epicardial radiofrequency catheter ablations (RFCA) are often successful for drug-resistant ventricular 
tachycardia (VT). However, a minority of VT circuits are intramural or septal and are not accessible using this approach. Transcoronary 
ethanol ablation is an effective alternative ablative technique in VTs refractory to endocardial and/or epicardial ablation, and can be a life-
saving procedure for deep intramural and/or septal VTs.
case:  A 69 year-old female with severe non-ischemic cardiomyopathy and paroxysmal VT was admitted for worsening fatigue and was 
found to be in hemodynamically stable incessant slow VT. The tachycardia cycle length was 566 milliseconds and the ECG showed a left 
bundle inferior axis morphology VT. She was on chronic amiodarone therapy and the VT was refractory to medical and device therapies. 
As such, the decision was made to proceed with electrophysiology study with electroanatomic (EA) mapping and attempted ablation. EA 
mapping revealed the VT focus to be within the mid antero-septum. Multiple endocardial ablations failed to terminate the VT and it was felt 
that the VT focus was deep within the septum and not amenable for RFCA.
decision Making:  At this point, coronary angiography was performed and a large septal perforator branching off the left anterior 
descending artery was identified. Injection of one milliliter of 2% lidocaine into this septal perforator immediately terminated the VT. 
Echocardiography utilizing echo contrast injected into the septal perforator demonstrated that it perfused only a small segment of the 
septum. Absolute ethanol was then injected into the septal perforator resulting in successful VT ablation. There were no complications and 
the patient was discharged in stable condition. There has been no sustained ventricular arrhythmia at 3 months of follow-up.
conclusion:  This case demonstrates successful transcoronary ethanol ablation of septal VT that was refractory to conventional therapies. 
Transcoronary ethanol ablation can be life-saving in ventricular tachycardias from re-entrant circuits deep within the myocardium, which are 
often inaccessible to both endocardial and epicardial ablation.
